Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tagrisso
Tagrisso
AstraZeneca's flagship Tagrisso helps lung cancer patients live longer in pivotal study
Endpoints
Fri, 08/9/19 - 10:28 am
AstraZeneca
Tagrisso
EGFR-mutated NSCLC
Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients
Fierce Pharma
Sun, 03/31/19 - 03:44 pm
Chi-Med
savolitinib
AstraZeneca
Tagrisso
EGFR lung cancer
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
In another try at lung cancer niche, J&J nabs a potential Tagrisso rival for $50M-plus
Endpoints
Mon, 11/5/18 - 07:17 pm
JNJ
Tagrisso
AstraZeneca
Yuhan
Major Expected Events from AstraZeneca’s R&D in H2 2018
Market Realist
Sat, 08/25/18 - 09:24 pm
AstraZeneca
China
Lynparza
Tagrisso
Imfinzi
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
Tue, 08/21/18 - 10:08 am
AstraZeneca
Japan
Tagrisso
non-small cell lung cancer
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
CP Wire
Thu, 04/19/18 - 12:30 am
Roche
cobas EGFR Mutation Test
Tagrisso
non-small cell lung cancer
AstraZeneca
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
Thu, 04/19/18 - 12:13 am
Roche
Tagrisso
non-small cell lung cancer
Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say
Biopharma Dive
Sat, 04/14/18 - 12:35 pm
Hanmi Pharm
Korea
lung cancer
Olita
AstraZeneca
Tagrisso
AstraZeneca's Tagrisso Label Expansion Filing Accepted by FDA
Yahoo/Zacks.com
Tue, 12/19/17 - 10:24 am
AstraZeneca
Tagrisso
FDA
labeling
non-small cell lung cancer
AstraZeneca touts Tagrisso's CNS benefit
BioPharma Dive
Tue, 11/21/17 - 09:45 am
Tagrisso
AstraZeneca
non-small cell lung cancer
CNS metastases
ESMO: AstraZeneca's Tagrisso bests rivals at holding off EGFR lung cancer growth
Fierce Pharma
Sat, 09/9/17 - 03:05 pm
AstraZeneca
ESMO
Tagrisso
FDA Approves Astra's Lung Cancer Drug
Investopedia
Fri, 03/31/17 - 10:09 pm
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
Mon, 03/27/17 - 09:38 am
AstraZeneca
China
Tagrisso
non-small cell lung cancer
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Market Realist
Tue, 03/21/17 - 06:56 pm
Japan
AstraZeneca
Tagrisso
Label Expansion May Boost Revenues for AstraZeneca’s Tagrisso
Market Realist
Tue, 01/3/17 - 09:49 am
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca’s Tagrisso Had a Strong Commercial Launch in 2016
Market Realist
Mon, 01/2/17 - 11:57 am
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca gives fuller picture of Tagrisso's edge in lung cancer
BioPharma Dive
Tue, 12/6/16 - 10:02 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca phase 3 trial confirms Tagrisso's efficacy
BioPharma Dive
Tue, 07/19/16 - 09:53 am
AstraZeneca
clinical trials
Tagrisso
non-small cell lung cancer
AstraZeneca lung cancer drug meets late-stage trial endpoint
Marketwatch
Mon, 07/18/16 - 09:48 am
AstraZeneca
lung cancer
clinical trials
Tagrisso
Pages
« first
‹ previous
1
2
3
4
next ›
last »